Analysis | Metabolite Name | Measured Value | Units | Gender | Glycemic status | Neuropathy |
---|---|---|---|---|---|---|
Reversed phase POSITIVE ION MODE | METHIONINE (M+H)+ | 2412401 | Peak area normalized | male | Normoglycemic | Neuropathy |
Reversed phase POSITIVE ION MODE | METHIONINE (M+H)+ | 2638396 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | METHIONINE (M+H)+ | 2756580 | Peak area normalized | female | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | METHIONINE (M+H)+ | 2773679 | Peak area normalized | male | Normoglycemic | Neuropathy |
Reversed phase POSITIVE ION MODE | METHIONINE (M+H)+ | 2784020 | Peak area normalized | female | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | METHIONINE (M+H)+ | 2863236 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | METHIONINE (M+H)+ | 2914806 | Peak area normalized | female | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | METHIONINE (M+H)+ | 2924503 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | METHIONINE (M+H)+ | 3080537 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | METHIONINE (M+H)+ | 3099504 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | METHIONINE (M+H)+ | 3120155 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | METHIONINE (M+H)+ | 3169564 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | METHIONINE (M+H)+ | 3190551 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | METHIONINE (M+H)+ | 3240639 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | METHIONINE (M+H)+ | 3298131 | Peak area normalized | female | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | METHIONINE (M+H)+ | 3356930 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | METHIONINE (M+H)+ | 3421660 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | METHIONINE (M+H)+ | 3496591 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | METHIONINE (M+H)+ | 3597557 | Peak area normalized | male | Normoglycemic | no neuropathy |
Reversed phase POSITIVE ION MODE | METHIONINE (M+H)+ | 3609936 | Peak area normalized | male | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | METHIONINE (M+H)+ | 3658038 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | METHIONINE (M+H)+ | 3693234 | Peak area normalized | male | Normoglycemic | no neuropathy |
Reversed phase POSITIVE ION MODE | METHIONINE (M+H)+ | 3736167 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | METHIONINE (M+H)+ | 3738686 | Peak area normalized | male | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | METHIONINE (M+H)+ | 3828335 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | METHIONINE (M+H)+ | 3932998 | Peak area normalized | male | Diabetic | no neuropathy |